Measures | Maternal Treatment | P-value | |
Control | Probiotics | ||
Plasma Cortisol, ng/mL | 35.2 ± 3.1 | 38.5 ± 3.12 | 0.447 |
White Blood Cell (WBC), 107/10 mL | 3.4 ± 0.48 | 3.5 ± 0.48 | 0.985 |
Neutrophils, % | 42.0 ± 1.3 | 36.8 ± 1.3 | 0.011 |
Lymphocytes, % | 55.5 ± 1.3 | 60.0 ± 1.3 | 0.021 |
Monocytes, % | 2.15 ± 0.41 | 2.22 ± 0.42 | 0.894 |
Eosinophils, % | 0.53 ± 0.09 | 0.65 ± 0.09 | 0.325 |
Neutrophil-to-Lymphocyte Ratio | 0.95 ± 0.07 | 0.72 ± 0.07 | 0.018 |
Chemotaxis-C5a, no./5 fields | 35.2 ± 7.2 | 80.4 ± 7.5 | <0.0001 |
Chemotaxis-IL8, no./5 fields | 43.1 ± 8.8 | 78.0 ± 9.4 | 0.008 |
Neutrophil phagocytosis, % | 62.8 ± 1.6 | 64.4 ± 1.6 | 0.490 |
NK Cytotoxicity, % | 64.0 ± 2.8 | 74.0 ± 2.7 | 0.047 |
Concanavalin-A proliferation | 2.32 ± 0.19 | 2.21 ± 0.19 | 0.584 |
Lipopolysaccharide proliferation | 1.20 ± 0.08 | 1.78 ± 0.08 | 0.017 |
Interleukin-12, pg/mL | 190.1 ± 21.5 | 299.5 ± 21.7 | 0.760 |